[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.194.83. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 105
Citations 0
Correction
August 2019

Error in Title

JAMA Oncol. 2019;5(8):1232. doi:10.1001/jamaoncol.2019.3304

In the Original Investigation titled, “Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate,” which published online June 27, 2019, in JAMA Oncology,1 there was an error in the title. The correct title is “Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.” This article was corrected online.

References
1.
Attard  G, Merseburger  AS, Wiebke  A,  et al.  Assessment of the safety of glucocorticoid regimens in combination with abiraterone acetate for metastatic castration-resistant prostate cancer  [published online June 27, 2019].  JAMA Oncol. doi:10.1001/jamaoncol.2019.1011Google Scholar
×